HomeModerna Inc

Moderna Inc

Moderna Beats Q1 Loss Expectations, Stock Surges on RSV and Spikevax Plans

Moderna Beats Q1 Loss Expectations, Stock Surges on RSV and Spikevax Plans

May 3, 2024

Moderna Forecasts $4 Billion in 2023 Sales from Private Market for COVID-19 Shots

Moderna Forecasts $4 Billion in 2023 Sales from Private Market for COVID-19 Shots

August 3, 2023

Moderna Stock: Take Advantage of Weakness

Moderna Stock: Take Advantage of Weakness

June 13, 2023

The Future Is Bright for Moderna, So Buy It Now

The Future Is Bright for Moderna, So Buy It Now

September 7, 2022

Moderna to Give Canada Omicron-Based COVID Vaccine Including 12 Million Doses

Moderna to Give Canada Omicron-Based COVID Vaccine Including 12 Million Doses

August 23, 2022